Results 1 to 10 of about 8,450 (130)

Demographic features and prognostic factors of uterine carcinosarcoma: a study at a specialized center in Saudi Arabia [PDF]

Frontiers in Oncology
ObjectivesUterine carcinosarcoma is a rare, aggressive biphasic tumor comprising both carcinomatous and sarcomatous elements. The overall prognosis of women with uterine carcinosarcoma is poor, with a median overall survival of less than two years.
Wala Mehros, Wala Mehros, Wala Mehros, Sarah Aldosari, Sarah Aldosari, Rahaf Alharbi, Rahaf Alharbi, Wasan Alshareef, Wasan Alshareef, Wesal Hawsawi, Wesal Hawsawi, Halah Fallata, Halah Fallata, Hatim Aljifree, Hatim Aljifree, Hatim Aljifree, Alaa Althubaiti, Alaa Althubaiti   +17 more
doaj   +2 more sources

A rare case report of uterine carcinosarcoma with bilateral ovarian Brenner tumors [PDF]

Frontiers in Oncology
BackgroundUterine carcinosarcoma is a rare, highly aggressive malignancy characterized by both carcinomatous and sarcomatous components. Brenner tumors of the ovary are uncommon epithelial neoplasms, usually benign but occasionally coexisting with other ...
Xinyao Wan, Fangfang Bi, Bing Xin, Chong Qiao   +3 more
doaj   +2 more sources

The discovery of uterine carcinosarcoma through a sister mary joseph's nodule: A case report [PDF]

Radiology Case Reports
The Sister Mary Joseph nodule is a rare sign of advanced malignancy, including uterine carcinosarcoma. A 55-year-old woman presented with a necrotic, bleeding 4 cm umbilical mass.
Wissal Jaafar, Medemagh Malak, Chiba Yasmine, Sadek Gueddana, Nahed Khalifa, Mechaal Mourali   +5 more
doaj   +2 more sources

Complete response to trastuzumab-deruxtecan (Enhertu, T-DXd) in HER2-positive stage IVB uterine carcinosarcoma [PDF]

Gynecologic Oncology Reports
Objectives: To report a case of complete response to trastuzumab-deruxtecan (T-DXd) in a patient with HER2-positive stage IVB uterine carcinosarcoma, and to contextualize this within evolving therapy for HER2-positive gynecologic malignancies.
Michael Kim, Amma Asare, Jamie L. Dockery, Nadia Hameed, Travis T. Sims   +4 more
doaj   +2 more sources

Peritoneal cytology predicting distant metastasis in uterine carcinosarcoma: machine learning model development and validation [PDF]

World Journal of Surgical Oncology
Objective This study develops and validates a machine learning model using peritoneal cytology to predict distant metastasis in uterine carcinosarcoma, aiding clinical decision-making.
Qiaoming Lin, Qi Guan, Danru Chen, Lilan Li, Yibin Lin   +4 more
doaj   +2 more sources

Case report: Characterization of the immunologic and molecular landscape in a unique presentation of invasive lobular carcinoma with concurrent uterine carcinosarcoma treated with immunotherapy [PDF]

Frontiers in Immunology
Invasive lobular breast cancer (ILC) is characterized by a relatively high risk for late recurrence and a unique metastatic pattern with an increased risk for metastasis to gynecologic organs and peritoneum. We present a unique case of recurrent ILC with
Courtney J. Riedinger, Caprice D. Eisele, Ashwini Esnakula, Daniel G. Stover, Aharon G. Freud, Casey M. Cosgrove   +5 more
doaj   +2 more sources

Elucidating divergent biology in uterine carcinosarcoma [PDF]

Translational Oncology
Objectives: Uterine carcinosarcoma (UCS) is an aggressive malignancy characterized by epithelial (C) and mesenchymal (S) components, with complex biology and poor treatment response.
Vikas Garg, Stephenie D. Prokopec, Simone C. Stone, Sara Pakbaz, Min Li Chen, Bernard Lam, Czin Czin Benito, Michelle Mcmullen, Ilinca Lungu, Samanta Del Rossi, Anthony Msan, Valerie Bowering, Valentin Sotov, Christine Tran, Marcus O. Butler, Amit M. Oza, Phedias Diamandis, Ben X. Wang, Stephanie Lheureux   +18 more
doaj   +2 more sources

Prognostic Significance of the Ki-67 Index with an Optimal Cut-off Value of 32.5% in Uterine Sarcoma and Uterine Carcinosarcoma: A Retrospective Cohort Study [PDF]

International Journal of Women's Health
Piaopiao Ye,1 Fang Wang,2 Xinyue Dai,1 Xiaoli Hu,1 Yuanqiu Wang11Department of Obstetrics and Gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People’s Republic of China; 2Department of Pathology, The First ...
Ye P, Wang F, Dai X, Hu X, Wang Y
doaj   +2 more sources

Carcinosarcoma of uterus

Radiology Case Reports, 2023
Uterine carcinosarcoma, which is categorized as high-grade endometrial cancer, is an uncommon kind of malignant gynecological neoplasms. Clinically, this tumor frequently affects menopausal women and the main symptom is abnormally postmenopausal vaginal ...
Ho Xuan Tuan, MD, PhD, Nguyen Minh Duc, MD, Cao Minh Tri, MD, Huynh-Thi Do Quyen, MD, Pham Xuan Dung, MD, PhD   +4 more
doaj   +1 more source

cERBB-2/Her-2 Neu Overexpression and Prognostic Significance in Uterine Carcinosarcoma

Türk Patoloji Dergisi, 2023
Objective: There is not enough data in the literature regarding Her-2 overexpression in uterine carcinosarcomas or its association with the prognosis. The aim of this study was to determine the Her-2 overexpression rate in uterine carcinosarcoma and to ...
Huseyin Salih SEMIZ, Emel Ebru PALA, Behzat CAN, Elif ATAG, Hatice GUNGOR, Muzaffer SANCI   +5 more
doaj   +1 more source